Breast Cancer Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Featured
Javier Cortes, MD, PhD, International Breast Cancer Center, discusses the role of immunotherapy in the first line treatment of metastatic triple-negative breast cancer, presented at the 2021 Great…
View More
Margaret Gatti-Mays, MD, MPH, FACP, Pelotonia Institute for Immuno‑Oncology, The Ohio State University, discusses treatment algorithms for metastatic HER2+ breast cancer, a topic discussed at the…
View More
Yuan Zhang, PhD, and Yi Xiao, PhD, discuss boosting immune surveillance with low-dose PI3K inhibitors to facilitate early intervention of breast cancer.
View More
Daniel Hayes, MD, discusses his recent debate with Nikhil Wagle, MD, regarding the benefits of extended endocrine therapy.
View More
Mariana Chavez Mac Gregor, MD, MSC, University of Texas, MD Anderson Cancer Center, highlights her approach to treating patients with metastatic HER2 + breast cancer.
View More
Mridula George, MD, Rutgers Cancer institute of New Jersey, discusses the addition of HER2 targeted agents within the last two decades that have been studied in the metastatic, adjuvant, and the…
View More
Olufunmilayo Olopade, MD, FACP, discusses the overhaul of precision oncology for true equity in cancer care, and brings focus to patient populations who have been understudied.
View More
Anthony Lucci, MD, highlights the significant results of a study on the role of MRM in patients with de novo stage IV inflammatory breast cancer.
View More
Adam Brufsky, MD, PhD, discusses evolving strategies in neoadjuvant/adjuvant treatment of early-stage TNBC.
View More
Stay in the know.
OncNet Newsletter